Drug General Information
Drug ID	D0P3ZN
Former ID	DNCL003385
Drug Name	RDEA3170
Indication	Hyperuricaemia [ICD9: 274, 274.00274.1274.8274.9, 790.6; ICD10:E79.0, M10]		Phase 2	[524664]
Company	AstraZeneca
Structure		Download 2D MOL 3D MOL
Target and Pathway
Target(s)	Solute carrier family 22 member 12	Target Info	Modulator	[544332]
WikiPathways	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds
References
Ref 524664	ClinicalTrials.gov (NCT02078219) Phase II Dose Finding Study of RDEA3170 Versus Placebo in Japanese Patients With Gout or Asymptomatic Hyperuricemia. U.S. National Institutes of Health.
Ref 544332	The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality. BMC Nephrol. 2013; 14: 164.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.